Ron Bentsur - Insider Trading Tracker

Nuvectis Pharma, Inc.

US ˙ NasdaqCM ˙ US67080T1088

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Ron Bentsur. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Se højest rangerende insidere

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Ron Bentsur har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed	Titel	Senest indberettede beholdninger
US:NVCT / Nuvectis Pharma, Inc.	Chairman & CEO, Director, 10% Owner	3.520.924
US:XAIR / Beyond Air, Inc.	Director	144.736
US:STML / Stemline Therapeutics, Inc.	Director	0
US:URGN / UroGen Pharma Ltd.	Chief Executive Officer, Director	76.226
US:KERX / Keryx Biopharmaceuticals, Inc.	Chief Executive Officer, Director	777.209

Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Ron Bentsur. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb NVCT / Nuvectis Pharma, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NVCT / Nuvectis Pharma, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Ticker	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Maks	Pris kl Maks	Maks Fortjeneste ($)	Maks. afkast (%)
2024-12-24	NVCT	BENTSUR RON	4.500	4,6500	4.500	4,6500	20.925	121	10.9600	28.395	135,70
2024-11-15	NVCT	BENTSUR RON	20.000	4,9200	20.000	4,9200	98.400
2024-05-14	NVCT	BENTSUR RON	1.940	6,7400	1.940	6,7400	13.076
2024-05-10	NVCT	BENTSUR RON	2.000	6,4000	2.000	6,4000	12.800
2024-03-18	NVCT	BENTSUR RON	5.000	10,2900	5.000	10,2900	51.450
2023-10-10	NVCT	BENTSUR RON	640	11,0800	640	11,0800	7.091
2023-10-09	NVCT	BENTSUR RON	830	11,1900	830	11,1900	9.288
2023-10-06	NVCT	BENTSUR RON	250	11,2700	250	11,2700	2.818
2023-10-05	NVCT	BENTSUR RON	1.400	11,0900	1.400	11,0900	15.526
2023-10-04	NVCT	BENTSUR RON	1.820	10,9500	1.820	10,9500	19.929
2023-08-16	NVCT	BENTSUR RON	115	15,1500	115	15,1500	1.742
2023-08-15	NVCT	BENTSUR RON	235	14,3400	235	14,3400	3.370
2023-08-11	NVCT	BENTSUR RON	180	14,6600	180	14,6600	2.639
2023-08-08	NVCT	BENTSUR RON	120	14,8300	120	14,8300	1.780
2023-07-21	NVCT	BENTSUR RON	225	14,8500	225	14,8500	3.341
2023-07-20	NVCT	BENTSUR RON	110	15,0600	110	15,0600	1.657
2023-07-19	NVCT	BENTSUR RON	200	14,3300	200	14,3300	2.866
2023-07-14	NVCT	BENTSUR RON	150	15,0300	150	15,0300	2.254
2023-07-07	NVCT	BENTSUR RON	110	16,1900	110	16,1900	1.781
2023-07-06	NVCT	BENTSUR RON	320	14,8800	320	14,8800	4.762
2023-06-26	NVCT	BENTSUR RON	750	16,5000	750	16,5000	12.375
2023-06-21	NVCT	BENTSUR RON	500	17,8800	500	17,8800	8.940
2023-06-08	NVCT	BENTSUR RON	120	17,5300	120	17,5300	2.104
2023-06-07	NVCT	BENTSUR RON	230	17,4100	230	17,4100	4.004
2023-05-31	NVCT	BENTSUR RON	330	17,2800	330	17,2800	5.702
2023-05-24	NVCT	BENTSUR RON	200	17,4900	200	17,4900	3.498
2023-05-16	NVCT	BENTSUR RON	320	17,0250	320	17,0250	5.448
2023-03-23	NVCT	BENTSUR RON	230	12,1300	230	12,1300	2.790
2023-03-21	NVCT	BENTSUR RON	480	12,0800	480	12,0800	5.798
2023-03-15	NVCT	BENTSUR RON	480	10,9100	480	10,9100	5.237
2023-03-14	NVCT	BENTSUR RON	1.680	10,8500	1.680	10,8500	18.228
2022-11-30	NVCT	BENTSUR RON	150	7,4500	150	7,4500	1.118
2022-11-29	NVCT	BENTSUR RON	150	7,4500	150	7,4500	1.118
2022-11-28	NVCT	BENTSUR RON	150	7,4000	150	7,4000	1.110
2022-11-25	NVCT	BENTSUR RON	150	7,3800	150	7,3800	1.107
2022-11-18	NVCT	BENTSUR RON	500	7,2300	500	7,2300	3.615
2022-11-17	NVCT	BENTSUR RON	250	7,2400	250	7,2400	1.810
2022-11-10	NVCT	BENTSUR RON	1.000	7,0700	1.000	7,0700	7.070
2022-09-30	NVCT	BENTSUR RON	500	7,4600	500	7,4600	3.730
2022-09-28	NVCT	BENTSUR RON	500	7,2300	500	7,2300	3.615
2022-09-26	NVCT	BENTSUR RON	500	7,6900	500	7,6900	3.845
2022-09-23	NVCT	BENTSUR RON	1.000	7,9300	1.000	7,9300	7.930
2022-09-02	NVCT	BENTSUR RON	1.200	8,3700	1.200	8,3700	10.044
2022-09-01	NVCT	BENTSUR RON	500	8,1100	500	8,1100	4.055
2022-08-29	NVCT	BENTSUR RON	1.000	9,0700	1.000	9,0700	9.070
2022-08-23	NVCT	BENTSUR RON	500	9,0000	500	9,0000	4.500
2022-08-19	NVCT	BENTSUR RON	5.000	8,9900	5.000	8,9900	44.950
2022-08-18	NVCT	BENTSUR RON	14.426	8,5800	14.426	8,5800	123.775
2022-08-11	NVCT	BENTSUR RON	19.669	8,4000	19.669	8,4000	165.220
2022-06-29	NVCT	BENTSUR RON	3.700	11,6200	3.700	11,6200	42.994
2022-06-28	NVCT	BENTSUR RON	300	11,8200	300	11,8200	3.546
2022-06-24	NVCT	BENTSUR RON	400	12,1800	400	12,1800	4.872
2022-06-23	NVCT	BENTSUR RON	200	11,4000	200	11,4000	2.280
2022-06-22	NVCT	BENTSUR RON	100	13,1000	100	13,1000	1.310
2022-05-27	NVCT	BENTSUR RON	500	15,7400	500	15,7400	7.870
2022-05-26	NVCT	BENTSUR RON	500	15,9000	500	15,9000	7.950
2022-05-20	NVCT	BENTSUR RON	1.000	16,2800	1.000	16,2800	16.280
2022-05-19	NVCT	BENTSUR RON	200	18,9500	200	18,9500	3.790
2022-05-18	NVCT	BENTSUR RON	700	20,6000	700	20,6000	14.420
2022-05-18	NVCT	BENTSUR RON	1.000	18,4900	1.000	18,4900	18.490
2022-05-17	NVCT	BENTSUR RON	200	19,7700	200	19,7700	3.954
2022-05-17	NVCT	BENTSUR RON	110	20,8300	110	20,8300	2.291
2022-05-16	NVCT	BENTSUR RON	1.000	19,3200	1.000	19,3200	19.320
2022-05-13	NVCT	BENTSUR RON	700	18,1000	700	18,1000	12.670
2022-05-12	NVCT	BENTSUR RON	1.100	14,8800	1.100	14,8800	16.368
2022-05-12	NVCT	BENTSUR RON	600	16,1200	600	16,1200	9.672
2022-05-12	NVCT	BENTSUR RON	10.545	17,2600	10.545	17,2600	182.007
2022-03-28	NVCT	BENTSUR RON	4.000	7,0500	4.000	7,0500	28.200
2022-03-17	NVCT	BENTSUR RON	7.000	7,6300	7.000	7,6300	53.410
2022-02-14	NVCT	BENTSUR RON	8.000	5,8800	8.000	5,8800	47.040
2022-02-10	NVCT	BENTSUR RON	8.500	6,3400	8.500	6,3400	53.890
2022-02-07	NVCT	BENTSUR RON	14.000	3,9300	14.000	3,9300	55.020
2022-02-07	NVCT	BENTSUR RON	6.000	8,2500	6.000	8,2500	49.500
2022-02-04	NVCT	BENTSUR RON	200.000	5,0000	200.000	5,0000	1.000.000
2022-02-04	NVCT	BENTSUR RON	12.500	3,8900	12.500	3,8900	48.625

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Insidersalg NVCT / Nuvectis Pharma, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NVCT / Nuvectis Pharma, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier Rapporteret
Pris Justeret
Aktier Justeret
Pris Omkostningsgrundlag dage til
Min Pris kl
Min Max tab
Undgået ($) Max tab
Undgået (%)

Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Insiderkøb URGN / UroGen Pharma Ltd. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NVCT / Nuvectis Pharma, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier Rapporteret
Pris Justeret
Aktier Justeret
Pris Omkostningsgrundlag dage til
Maks Pris kl
Maks Maks
Fortjeneste ($) Maks. afkast (%)

Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Insidersalg URGN / UroGen Pharma Ltd. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NVCT / Nuvectis Pharma, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier Rapporteret
Pris Justeret
Aktier Justeret
Pris Omkostningsgrundlag dage til
Min Pris kl
Min Max tab
Undgået ($) Max tab
Undgået (%)

Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Insiderkøb XAIR / Beyond Air, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NVCT / Nuvectis Pharma, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier Rapporteret
Pris Justeret
Aktier Justeret
Pris Omkostningsgrundlag dage til
Maks Pris kl
Maks Maks
Fortjeneste ($) Maks. afkast (%)

2023-03-20 XAIR BENTSUR RON 2.300 6,4800 115 129,6000 14.904 15 6.9200 -14.108 -94,66

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Insidersalg XAIR / Beyond Air, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NVCT / Nuvectis Pharma, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier Rapporteret
Pris Justeret
Aktier Justeret
Pris Omkostningsgrundlag dage til
Min Pris kl
Min Max tab
Undgået ($) Max tab
Undgået (%)

2022-06-30 XAIR BENTSUR RON 40.000 6,5276 2.000 130,5520 261.104 365 4.2600 -252.584 -96,74

2021-11-24 XAIR BENTSUR RON 31.000 13,4400 1.550 268,8000 416.640

2021-11-24 XAIR BENTSUR RON 6.464 13,9900 323 279,8000 90.431

2021-02-12 XAIR BENTSUR RON 23.419 6,3600 1.171 127,2000 148.945

2021-02-11 XAIR BENTSUR RON 1.500 6,2800 75 125,6000 9.420

2021-01-02 XAIR BENTSUR RON 5.700 5,8900 285 117,8000 33.573

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Ron Bentsur som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om Del
Pris Tran
Værdi Tilbage
Værdi

2025-01-03 2025-01-02 4 NVCT Nuvectis Pharma, Inc.
Common Stock A - Award 250.000 3.520.924 7,64

2024-12-26 2024-12-24 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 4.500 3.270.924 0,14 4,65 20.925 15.209.797

2024-11-18 2024-11-15 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 20.000 3.266.424 0,62 4,92 98.400 16.070.806

2024-05-15 2024-05-14 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.940 3.246.424 0,06 6,74 13.076 21.880.898

2024-05-13 2024-05-10 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 2.000 3.244.484 0,06 6,40 12.800 20.764.698

2024-03-19 2024-03-18 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 5.000 3.242.484 0,15 10,29 51.450 33.365.160

2023-10-12 2023-10-10 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 640 3.237.484 0,02 11,08 7.091 35.871.323

2023-10-10 2023-10-09 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 830 3.236.844 0,03 11,19 9.288 36.220.284

2023-10-10 2023-10-06 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 250 3.236.014 0,01 11,27 2.818 36.469.878

2023-10-06 2023-10-05 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.400 3.235.764 0,04 11,09 15.526 35.884.623

2023-10-06 2023-10-04 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.820 3.234.364 0,06 10,95 19.929 35.416.286

2023-08-16 2023-08-16 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 115 3.232.544 0,00 15,15 1.742 48.973.042

2023-08-16 2023-08-15 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 235 3.232.429 0,01 14,34 3.370 46.353.032

2023-08-11 2023-08-11 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 180 3.232.194 0,01 14,66 2.639 47.383.964

2023-08-11 2023-08-08 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 120 3.232.014 0,00 14,83 1.780 47.930.768

2023-07-24 2023-07-21 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 225 3.231.894 0,01 14,85 3.341 47.993.626

2023-07-24 2023-07-20 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 110 3.231.669 0,00 15,06 1.657 48.668.935

2023-07-20 2023-07-19 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 200 3.231.559 0,01 14,33 2.866 46.308.240

2023-07-18 2023-07-14 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 150 3.231.359 0,00 15,03 2.254 48.567.326

2023-07-18 2023-07-07 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 110 3.231.209 0,00 16,19 1.781 52.313.274

2023-07-07 2023-07-06 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 320 3.231.099 0,01 14,88 4.762 48.078.753

2023-06-27 2023-06-26 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 750 3.230.779 0,02 16,50 12.375 53.307.854

2023-06-22 2023-06-21 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 500 3.230.029 0,02 17,88 8.940 57.752.919

2023-06-08 2023-06-08 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 120 3.229.529 0,00 17,53 2.104 56.613.643

2023-06-08 2023-06-07 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 230 3.229.409 0,01 17,41 4.004 56.224.011

2023-06-01 2023-05-31 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 330 3.229.179 0,01 17,28 5.702 55.800.213

2023-05-26 2023-05-24 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 200 3.228.849 0,01 17,49 3.498 56.472.569

2023-05-18 2023-05-16 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 320 3.228.649 0,01 17,02 5.448 54.967.749

2023-03-27 2023-03-23 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 230 3.228.329 0,01 12,13 2.790 39.159.631

2023-03-23 2023-03-21 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 480 3.228.099 0,01 12,08 5.798 38.995.436

2023-03-21 2023-03-20 4 XAIR Beyond Air, Inc.
Common Stock P - Purchase 2.300 144.736 1,61 6,48 14.904 937.889

2023-03-16 2023-03-15 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 480 3.227.619 0,01 10,91 5.237 35.213.323

2023-03-16 2023-03-14 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.680 3.227.139 0,05 10,85 18.228 35.014.458

2023-01-13 2023-01-12 4 NVCT Nuvectis Pharma, Inc.
Common Stock A - Award 210.000 3.225.459 6,96

2022-11-30 2022-11-30 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 150 3.015.459 0,00 7,45 1.118 22.465.170

2022-11-29 2022-11-29 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 150 3.015.309 0,00 7,45 1.118 22.464.052

2022-11-29 2022-11-28 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 150 3.015.159 0,00 7,40 1.110 22.312.177

2022-11-29 2022-11-25 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 150 3.015.009 0,00 7,38 1.107 22.250.766

2022-11-21 2022-11-18 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 500 3.014.859 0,02 7,23 3.615 21.797.431

2022-11-21 2022-11-17 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 250 3.014.359 0,01 7,24 1.810 21.823.959

2022-11-16 2022-11-10 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.000 3.014.109 0,03 7,07 7.070 21.309.751

2022-10-03 2022-09-30 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 500 3.013.109 0,02 7,46 3.730 22.477.793

2022-10-03 2022-09-28 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 500 3.012.609 0,02 7,23 3.615 21.781.163

2022-09-27 2022-09-26 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 500 3.012.109 0,02 7,69 3.845 23.163.118

2022-09-27 2022-09-23 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.000 3.011.609 0,03 7,93 7.930 23.882.059

2022-09-06 2022-09-02 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.200 3.010.609 0,04 8,37 10.044 25.198.797

2022-09-06 2022-09-01 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 500 3.009.409 0,02 8,11 4.055 24.406.307

2022-08-30 2022-08-29 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.000 3.008.909 0,03 9,07 9.070 27.290.805

2022-08-30 2022-08-23 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 500 3.007.909 0,02 9,00 4.500 27.071.181

2022-08-22 2022-08-19 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 5.000 3.007.409 0,17 8,99 44.950 27.036.607

2022-08-22 2022-08-18 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 14.426 3.002.409 0,48 8,58 123.775 25.760.669

2022-08-16 2022-08-11 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 19.669 2.987.983 0,66 8,40 165.220 25.099.057

2022-07-05 2022-06-30 4 XAIR Beyond Air, Inc.
Common Stock S - Sale -40.000 142.436 -21,93 6,53 -261.104 929.765

2022-06-30 2022-06-29 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 3.700 2.968.314 0,12 11,62 42.994 34.491.809

2022-06-30 2022-06-28 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 300 2.964.614 0,01 11,82 3.546 35.041.737

2022-06-27 2022-06-24 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 400 2.964.314 0,01 12,18 4.872 36.105.345

2022-06-27 2022-06-23 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 200 2.963.914 0,01 11,40 2.280 33.788.620

2022-06-27 2022-06-22 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 100 2.963.714 0,00 13,10 1.310 38.824.653

2022-05-31 2022-05-27 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 500 2.963.614 0,02 15,74 7.870 46.647.284

2022-05-31 2022-05-26 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 500 2.963.114 0,02 15,90 7.950 47.113.513

2022-05-23 2022-05-20 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.000 2.962.614 0,03 16,28 16.280 48.231.356

2022-05-23 2022-05-19 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 200 2.961.614 0,01 18,95 3.790 56.122.585

2022-05-19 2022-05-18 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.000 2.961.414 0,03 18,49 18.490 54.756.545

2022-05-19 2022-05-18 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 700 2.960.414 0,02 20,60 14.420 60.984.528

2022-05-19 2022-05-17 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 110 2.959.714 0,00 20,83 2.291 61.650.843

2022-05-19 2022-05-17 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 200 2.959.604 0,01 19,77 3.954 58.511.371

2022-05-17 2022-05-16 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.000 2.959.404 0,03 19,32 19.320 57.175.685

2022-05-17 2022-05-13 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 700 2.958.404 0,02 18,10 12.670 53.547.112

2022-05-13 2022-05-12 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 10.545 2.957.704 0,36 17,26 182.007 51.049.971

2022-05-13 2022-05-12 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 600 2.947.159 0,02 16,12 9.672 47.508.203

2022-05-13 2022-05-12 4 NVCT Nuvectis Pharma, Inc.
Common Stock P - Purchase 1.100 2.946.559 0,04 14,88 16.368 43.844.798

2022-04-05 2022-04-01 4 NVCT Nuvectis Pharma, Inc.
Common Stock A - Award 120.000 2.945.459 4,25

2022-03-29 2022-03-28 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 P - Purchase 4.000 2.825.459 0,14 7,05 28.200 19.919.486

2022-03-18 2022-03-17 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 P - Purchase 7.000 2.821.459 0,25 7,63 53.410 21.527.732

2022-03-07 2022-03-03 4 XAIR Beyond Air, Inc.
Stock Option (right to buy) A - Award 30.000 30.000

2022-02-15 2022-02-14 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 P - Purchase 8.000 2.814.459 0,29 5,88 47.040 16.549.019

2022-02-11 2022-02-10 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 P - Purchase 8.500 2.806.459 0,30 6,34 53.890 17.792.950

2022-02-08 3 NVCT Nuvectis Pharma, Inc.
Common Stock 2.565.459

2022-02-08 2022-02-07 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 P - Purchase 6.000 2.797.959 0,21 8,25 49.500 23.083.162

2022-02-08 2022-02-07 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 P - Purchase 14.000 2.791.959 0,50 3,93 55.020 10.972.399

2022-02-08 2022-02-04 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 P - Purchase 12.500 2.777.959 0,45 3,89 48.625 10.806.261

2022-02-08 2022-02-04 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 P - Purchase 200.000 2.765.459 7,80 5,00 1.000.000 13.827.295

2021-11-26 2021-11-24 4 XAIR Beyond Air, Inc.
Common Stock S - Sale -6.464 182.436 -3,42 13,99 -90.431 2.552.280

2021-11-26 2021-11-24 4 XAIR Beyond Air, Inc.
Common Stock S - Sale -31.000 188.900 -14,10 13,44 -416.640 2.538.816

2021-11-24 2021-11-22 4 XAIR Beyond Air, Inc.
Warrants (right to buy) M - Exercise -50.000 0 -100,00

2021-11-24 2021-11-22 4 XAIR Beyond Air, Inc.
Common Stock F - Taxes -12.536 219.900 -5,39 14,60 -182.988 3.209.880

2021-11-24 2021-11-22 4 XAIR Beyond Air, Inc.
Common Stock M - Exercise 50.000 232.436 27,41 3,66 183.000 850.716

2021-03-08 2021-03-04 4 XAIR Beyond Air, Inc.
Stock Option (right to buy) A - Award 25.000 25.000

2021-02-18 2021-02-12 4 XAIR Beyond Air, Inc.
Tranche B Warrant (Right to Buy) M - Exercise -23.419 0 -100,00

2021-02-18 2021-02-12 4 XAIR Beyond Air, Inc.
Common Stock S - Sale -23.419 182.436 -11,38 6,36 -148.945 1.160.293

2021-02-18 2021-02-12 4 XAIR Beyond Air, Inc.
Common Stock M - Exercise 23.419 205.855 12,84 4,25 99.531 874.884

2021-02-18 2021-02-11 4 XAIR Beyond Air, Inc.
Common Stock S - Sale -1.500 182.436 -0,82 6,28 -9.420 1.145.698

2021-02-08 2021-01-02 4 XAIR Beyond Air, Inc.
Common Stock S - Sale -5.700 183.936 -3,01 5,89 -33.573 1.083.383

2020-08-27 2020-08-25 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -1.580 189.636 -0,83 5,95 -9.406 1.128.960

2020-08-25 2020-08-24 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -3.889 191.216 -1,99 5,68 -22.104 1.086.834

2020-08-25 2020-08-21 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -3.246 195.105 -1,64 6,05 -19.651 1.181.127

2020-08-21 2020-08-20 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -3.778 198.351 -1,87 6,29 -23.780 1.248.481

2020-08-21 2020-08-19 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -6.533 202.129 -3,13 6,32 -41.266 1.276.748

2020-08-19 2020-08-18 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -4.578 208.662 -2,15 5,83 -26.691 1.216.562

2020-08-18 2020-08-17 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -4.413 213.240 -2,03 5,72 -25.226 1.218.944

2020-08-17 2020-08-14 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -6.680 217.653 -2,98 5,53 -36.932 1.203.338

2020-08-14 2020-08-13 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -4.088 224.333 -1,79 5,50 -22.494 1.234.392

2020-08-13 2020-08-12 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -4.689 228.421 -2,01 5,30 -24.834 1.209.786

2020-08-12 2020-07-27 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -4.917 278.582 -1,73 6,27 -30.807 1.745.428

2020-08-12 2020-08-11 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -3.910 233.110 -1,65 5,51 -21.553 1.284.949

2020-08-12 2020-08-10 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -3.437 237.020 -1,43 5,42 -18.636 1.285.146

2020-08-10 2020-08-07 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -10.222 245.374 -4,00 5,35 -54.657 1.312.015

2020-08-07 2020-08-06 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -6.192 255.596 -2,37 5,94 -36.777 1.518.112

2020-08-07 2020-08-05 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -3.619 261.788 -1,36 6,16 -22.286 1.612.117

2020-08-06 2020-08-04 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -3.649 265.407 -1,36 6,13 -22.369 1.627.025

2020-08-04 2020-08-03 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -3.814 269.056 -1,40 6,16 -23.489 1.656.981

2020-08-04 2020-07-31 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -2.868 272.870 -1,04 6,27 -17.970 1.709.694

2020-07-31 2020-07-30 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -3.418 275.738 -1,22 6,26 -21.404 1.726.699

2020-07-31 2020-07-29 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -1.827 279.156 -0,65 6,09 -11.135 1.701.400

2020-07-31 2020-07-29 4 XAIR Beyond Air, Inc.
Common Stock S - Sale X -2.516 280.983 -0,89 6,20 -15.596 1.741.757

2020-06-10 2020-06-10 4 STML STEMLINE THERAPEUTICS INC
Stock Option (right to buy) D - Sale to Issuer -24.000 0 -100,00

2020-06-10 2020-06-10 4 STML STEMLINE THERAPEUTICS INC
Stock Option (right to buy) D - Sale to Issuer -34.000 0 -100,00

2020-06-10 2020-06-10 4 STML STEMLINE THERAPEUTICS INC
Stock Option (right to buy) D - Sale to Issuer -18.070 0 -100,00

2020-06-10 2020-06-10 4 STML STEMLINE THERAPEUTICS INC
Stock Option (right to buy) D - Sale to Issuer -9.034 0 -100,00

2020-06-10 2020-06-10 4 STML STEMLINE THERAPEUTICS INC
Common Stock U - Other -66.346 0 -100,00

2019-06-28 2019-06-25 4 STML STEMLINE THERAPEUTICS INC
Common Stock A - Award 10.000 65.443 18,04

2019-06-28 2019-06-25 4 STML STEMLINE THERAPEUTICS INC
Common Stock A - Award 15.000 55.443 37,09

2019-01-10 3 URGN UroGen Pharma Ltd.
Ordinary Shares 76.226

2019-01-10 3 URGN UroGen Pharma Ltd.
Ordinary Shares 76.226

2019-01-10 3 URGN UroGen Pharma Ltd.
Ordinary Shares 76.226

2018-06-22 2018-06-21 4 STML STEMLINE THERAPEUTICS INC
Common Stock A - Award 13.158 40.443 48,22

2018-05-15 2018-02-16 4 AITB AIT Therapeutics, Inc.
Tranche A Warrant (right to buy) M - Exercise -23.419 0 -100,00

2018-05-15 2018-02-16 4 AITB AIT Therapeutics, Inc.
Tranche A Warrant (right to buy) P - Purchase 23.419 23.419 0,01 234 234

2018-05-15 2018-02-16 4 AITB AIT Therapeutics, Inc.
Tranche B Warrant (right to buy) P - Purchase 23.419 23.419 0,01 234 234

2018-05-15 2018-02-16 4 AITB AIT Therapeutics, Inc.
Common Stock M - Exercise 23.419 283.499 9,00 4,25 99.531 1.204.871

2017-06-20 2017-06-19 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) A - Award 24.000 24.000

2017-06-20 2017-06-19 4 STML STEMLINE THERAPEUTICS INC
Common Stock A - Award 10.000 27.285 57,85

2017-06-20 3 AITB AIT Therapeutics, Inc.
Common Stock 520.158

2017-06-20 3 AITB AIT Therapeutics, Inc.
Common Stock 520.158

2016-05-26 2016-05-25 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) A - Award 34.000 34.000

2015-06-25 2015-06-23 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) A - Award 24.000 24.000

2015-06-25 2015-06-23 4 STML STEMLINE THERAPEUTICS INC
Common Stock A - Award 10.000 17.285 137,27

2015-04-08 2015-04-06 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -1.592 777.209 -0,20 11,68 -18.595 9.077.801

2015-03-20 2015-03-18 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) M - Exercise -5.421 0 -100,00

2015-03-20 2015-03-18 4 STML STEMLINE THERAPEUTICS INC
Common Stock S - Sale -1.388 7.285 -16,00 16,12 -22.375 117.434

2015-03-20 2015-03-18 4 STML STEMLINE THERAPEUTICS INC
Common Stock M - Exercise 5.421 8.673 166,70 4,09 22.172 35.473

2015-01-06 2015-01-05 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -5.574 778.801 -0,71 13,79 -76.865 10.739.666

2015-01-06 2015-01-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Employee Stock Option (Right to Buy) A - Award 134.750 134.750

2015-01-06 2015-01-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock A - Award 67.375 784.375 9,40

2015-01-02 2014-12-30 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -200.000 717.000 -21,81 14,11 -2.822.000 10.116.870

2014-12-29 2014-12-29 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -87.988 917.000 -8,76 13,98 -1.230.072 12.819.660

2014-12-29 2014-12-26 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -63.500 1.004.988 -5,94 13,98 -887.730 14.049.732

2014-12-29 2014-12-24 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -83.000 1.068.488 -7,21 13,98 -1.160.340 14.937.462

2014-12-29 2014-12-23 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -104.489 1.151.488 -8,32 13,98 -1.460.756 16.097.802

2014-12-23 2014-12-22 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock A - Award 500.000 1.255.977 66,14

2014-10-07 2014-10-06 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -68.800 755.977 -8,34 15,87 -1.091.856 11.997.355

2014-10-07 2014-10-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -2.038 824.777 -0,25 16,14 -32.893 13.311.901

2014-09-12 2014-09-12 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -50.000 826.815 -5,70 14,24 -712.000 11.773.846

2014-07-09 2014-07-07 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -1.788 876.815 -0,20 15,75 -28.161 13.809.836

2014-06-23 2014-06-19 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) A - Award 20.000 20.000

2014-04-07 2014-04-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -1.816 878.603 -0,21 16,46 -29.891 14.461.805

2014-01-06 2014-01-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -5.257 880.419 -0,59 12,57 -66.080 11.066.867

2014-01-06 2014-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Employee Stock Option (Right to Buy) A - Award 62.092 62.092

2014-01-06 2014-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock A - Award 26.611 885.676 3,10

2013-10-08 2013-10-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock A - Award 400.000 859.065 87,13

2013-10-07 2013-10-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -2.505 459.065 -0,54 10,25 -25.676 4.705.416

2013-07-09 2013-07-05 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -2.440 461.570 -0,53 7,95 -19.398 3.669.482

2013-06-21 2013-06-19 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) A - Award 20.000 20.000

2013-04-08 2013-04-05 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -1.795 464.010 -0,39 6,93 -12.439 3.215.589

2013-03-29 2013-03-27 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -31.231 465.805 -6,28 6,88 -214.869 3.204.738

2013-01-28 3 STML STEMLINE THERAPEUTICS INC
Common Stock 3.252

2013-01-04 2013-01-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -6.010 497.036 -1,19 2,74 -16.467 1.361.879

2013-01-04 2013-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Employee Stock Option (right to buy) A - Award 75.000 75.000

2013-01-04 2013-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock A - Award 25.000 503.046 5,23

2012-10-05 2012-10-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -746 478.046 -0,16 2,72 -2.029 1.300.285

2012-07-06 2012-07-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -684 478.792 -0,14 1,99 -1.361 952.796

2012-04-19 2012-04-18 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock P - Purchase 3.800 479.476 0,80 1,28 4.883 616.127

2012-04-19 2012-04-18 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock P - Purchase 15.300 475.676 3,32 1,30 19.890 618.379

2012-04-04 2012-04-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock P - Purchase 71.400 460.376 18,36 1,38 98.525 635.273

2012-01-03 2012-01-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock S - Sale -3.305 388.976 -0,84 2,62 -8.676 1.021.062

2012-01-03 2012-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Employee Stock Options (Right to Buy) A - Award 67.000 67.000

2012-01-03 2012-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock A - Award 33.000 392.281 9,19

P

Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer

S

Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer

A

Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)

C

Konvertering af derivat

D

Salg eller overførsel af værdipapirer tilbage til virksomheden

F

Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet

G

Gave af værdipapirer af eller til insideren

K

Aktieswaps og lignende sikringstransaktioner

M

Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)

V

En transaktion rapporteret frivilligt på formular 4

J

Andet (ledsaget af en fodnote, der beskriver transaktionen)

Handelsdato	Ticker	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Min	Pris kl Min	Max tab Undgået ($)	Max tab Undgået (%)
2022-06-30	XAIR	BENTSUR RON	40.000	6,5276	2.000	130,5520	261.104	365	4.2600	-252.584	-96,74
2021-11-24	XAIR	BENTSUR RON	31.000	13,4400	1.550	268,8000	416.640
2021-11-24	XAIR	BENTSUR RON	6.464	13,9900	323	279,8000	90.431
2021-02-12	XAIR	BENTSUR RON	23.419	6,3600	1.171	127,2000	148.945
2021-02-11	XAIR	BENTSUR RON	1.500	6,2800	75	125,6000	9.420
2021-01-02	XAIR	BENTSUR RON	5.700	5,8900	285	117,8000	33.573

Fil dato	Transdato	Form	Ticker	Sikkerhed	Kode	10b5-1	Aktier	Resterende aktier	Procent Lave om	Del Pris	Tran Værdi	Tilbage Værdi
2025-01-03	2025-01-02	4	NVCT	Nuvectis Pharma, Inc. Common Stock	A - Award		250.000	3.520.924	7,64
2024-12-26	2024-12-24	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		4.500	3.270.924	0,14	4,65	20.925	15.209.797
2024-11-18	2024-11-15	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		20.000	3.266.424	0,62	4,92	98.400	16.070.806
2024-05-15	2024-05-14	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.940	3.246.424	0,06	6,74	13.076	21.880.898
2024-05-13	2024-05-10	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		2.000	3.244.484	0,06	6,40	12.800	20.764.698
2024-03-19	2024-03-18	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		5.000	3.242.484	0,15	10,29	51.450	33.365.160
2023-10-12	2023-10-10	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		640	3.237.484	0,02	11,08	7.091	35.871.323
2023-10-10	2023-10-09	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		830	3.236.844	0,03	11,19	9.288	36.220.284
2023-10-10	2023-10-06	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		250	3.236.014	0,01	11,27	2.818	36.469.878
2023-10-06	2023-10-05	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.400	3.235.764	0,04	11,09	15.526	35.884.623
2023-10-06	2023-10-04	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.820	3.234.364	0,06	10,95	19.929	35.416.286
2023-08-16	2023-08-16	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		115	3.232.544	0,00	15,15	1.742	48.973.042
2023-08-16	2023-08-15	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		235	3.232.429	0,01	14,34	3.370	46.353.032
2023-08-11	2023-08-11	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		180	3.232.194	0,01	14,66	2.639	47.383.964
2023-08-11	2023-08-08	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		120	3.232.014	0,00	14,83	1.780	47.930.768
2023-07-24	2023-07-21	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		225	3.231.894	0,01	14,85	3.341	47.993.626
2023-07-24	2023-07-20	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		110	3.231.669	0,00	15,06	1.657	48.668.935
2023-07-20	2023-07-19	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		200	3.231.559	0,01	14,33	2.866	46.308.240
2023-07-18	2023-07-14	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		150	3.231.359	0,00	15,03	2.254	48.567.326
2023-07-18	2023-07-07	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		110	3.231.209	0,00	16,19	1.781	52.313.274
2023-07-07	2023-07-06	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		320	3.231.099	0,01	14,88	4.762	48.078.753
2023-06-27	2023-06-26	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		750	3.230.779	0,02	16,50	12.375	53.307.854
2023-06-22	2023-06-21	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		500	3.230.029	0,02	17,88	8.940	57.752.919
2023-06-08	2023-06-08	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		120	3.229.529	0,00	17,53	2.104	56.613.643
2023-06-08	2023-06-07	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		230	3.229.409	0,01	17,41	4.004	56.224.011
2023-06-01	2023-05-31	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		330	3.229.179	0,01	17,28	5.702	55.800.213
2023-05-26	2023-05-24	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		200	3.228.849	0,01	17,49	3.498	56.472.569
2023-05-18	2023-05-16	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		320	3.228.649	0,01	17,02	5.448	54.967.749
2023-03-27	2023-03-23	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		230	3.228.329	0,01	12,13	2.790	39.159.631
2023-03-23	2023-03-21	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		480	3.228.099	0,01	12,08	5.798	38.995.436
2023-03-21	2023-03-20	4	XAIR	Beyond Air, Inc. Common Stock	P - Purchase		2.300	144.736	1,61	6,48	14.904	937.889
2023-03-16	2023-03-15	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		480	3.227.619	0,01	10,91	5.237	35.213.323
2023-03-16	2023-03-14	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.680	3.227.139	0,05	10,85	18.228	35.014.458
2023-01-13	2023-01-12	4	NVCT	Nuvectis Pharma, Inc. Common Stock	A - Award		210.000	3.225.459	6,96
2022-11-30	2022-11-30	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		150	3.015.459	0,00	7,45	1.118	22.465.170
2022-11-29	2022-11-29	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		150	3.015.309	0,00	7,45	1.118	22.464.052
2022-11-29	2022-11-28	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		150	3.015.159	0,00	7,40	1.110	22.312.177
2022-11-29	2022-11-25	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		150	3.015.009	0,00	7,38	1.107	22.250.766
2022-11-21	2022-11-18	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		500	3.014.859	0,02	7,23	3.615	21.797.431
2022-11-21	2022-11-17	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		250	3.014.359	0,01	7,24	1.810	21.823.959
2022-11-16	2022-11-10	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.000	3.014.109	0,03	7,07	7.070	21.309.751
2022-10-03	2022-09-30	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		500	3.013.109	0,02	7,46	3.730	22.477.793
2022-10-03	2022-09-28	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		500	3.012.609	0,02	7,23	3.615	21.781.163
2022-09-27	2022-09-26	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		500	3.012.109	0,02	7,69	3.845	23.163.118
2022-09-27	2022-09-23	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.000	3.011.609	0,03	7,93	7.930	23.882.059
2022-09-06	2022-09-02	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.200	3.010.609	0,04	8,37	10.044	25.198.797
2022-09-06	2022-09-01	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		500	3.009.409	0,02	8,11	4.055	24.406.307
2022-08-30	2022-08-29	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.000	3.008.909	0,03	9,07	9.070	27.290.805
2022-08-30	2022-08-23	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		500	3.007.909	0,02	9,00	4.500	27.071.181
2022-08-22	2022-08-19	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		5.000	3.007.409	0,17	8,99	44.950	27.036.607
2022-08-22	2022-08-18	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		14.426	3.002.409	0,48	8,58	123.775	25.760.669
2022-08-16	2022-08-11	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		19.669	2.987.983	0,66	8,40	165.220	25.099.057
2022-07-05	2022-06-30	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale		-40.000	142.436	-21,93	6,53	-261.104	929.765
2022-06-30	2022-06-29	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		3.700	2.968.314	0,12	11,62	42.994	34.491.809
2022-06-30	2022-06-28	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		300	2.964.614	0,01	11,82	3.546	35.041.737
2022-06-27	2022-06-24	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		400	2.964.314	0,01	12,18	4.872	36.105.345
2022-06-27	2022-06-23	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		200	2.963.914	0,01	11,40	2.280	33.788.620
2022-06-27	2022-06-22	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		100	2.963.714	0,00	13,10	1.310	38.824.653
2022-05-31	2022-05-27	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		500	2.963.614	0,02	15,74	7.870	46.647.284
2022-05-31	2022-05-26	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		500	2.963.114	0,02	15,90	7.950	47.113.513
2022-05-23	2022-05-20	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.000	2.962.614	0,03	16,28	16.280	48.231.356
2022-05-23	2022-05-19	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		200	2.961.614	0,01	18,95	3.790	56.122.585
2022-05-19	2022-05-18	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.000	2.961.414	0,03	18,49	18.490	54.756.545
2022-05-19	2022-05-18	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		700	2.960.414	0,02	20,60	14.420	60.984.528
2022-05-19	2022-05-17	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		110	2.959.714	0,00	20,83	2.291	61.650.843
2022-05-19	2022-05-17	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		200	2.959.604	0,01	19,77	3.954	58.511.371
2022-05-17	2022-05-16	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.000	2.959.404	0,03	19,32	19.320	57.175.685
2022-05-17	2022-05-13	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		700	2.958.404	0,02	18,10	12.670	53.547.112
2022-05-13	2022-05-12	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		10.545	2.957.704	0,36	17,26	182.007	51.049.971
2022-05-13	2022-05-12	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		600	2.947.159	0,02	16,12	9.672	47.508.203
2022-05-13	2022-05-12	4	NVCT	Nuvectis Pharma, Inc. Common Stock	P - Purchase		1.100	2.946.559	0,04	14,88	16.368	43.844.798
2022-04-05	2022-04-01	4	NVCT	Nuvectis Pharma, Inc. Common Stock	A - Award		120.000	2.945.459	4,25
2022-03-29	2022-03-28	4	NVCT	Nuvectis Pharma, Inc. Common Stock, par value $0.00001	P - Purchase		4.000	2.825.459	0,14	7,05	28.200	19.919.486
2022-03-18	2022-03-17	4	NVCT	Nuvectis Pharma, Inc. Common Stock, par value $0.00001	P - Purchase		7.000	2.821.459	0,25	7,63	53.410	21.527.732
2022-03-07	2022-03-03	4	XAIR	Beyond Air, Inc. Stock Option (right to buy)	A - Award		30.000	30.000
2022-02-15	2022-02-14	4	NVCT	Nuvectis Pharma, Inc. Common Stock, par value $0.00001	P - Purchase		8.000	2.814.459	0,29	5,88	47.040	16.549.019
2022-02-11	2022-02-10	4	NVCT	Nuvectis Pharma, Inc. Common Stock, par value $0.00001	P - Purchase		8.500	2.806.459	0,30	6,34	53.890	17.792.950
2022-02-08		3	NVCT	Nuvectis Pharma, Inc. Common Stock				2.565.459
2022-02-08	2022-02-07	4	NVCT	Nuvectis Pharma, Inc. Common Stock, par value $0.00001	P - Purchase		6.000	2.797.959	0,21	8,25	49.500	23.083.162
2022-02-08	2022-02-07	4	NVCT	Nuvectis Pharma, Inc. Common Stock, par value $0.00001	P - Purchase		14.000	2.791.959	0,50	3,93	55.020	10.972.399
2022-02-08	2022-02-04	4	NVCT	Nuvectis Pharma, Inc. Common Stock, par value $0.00001	P - Purchase		12.500	2.777.959	0,45	3,89	48.625	10.806.261
2022-02-08	2022-02-04	4	NVCT	Nuvectis Pharma, Inc. Common Stock, par value $0.00001	P - Purchase		200.000	2.765.459	7,80	5,00	1.000.000	13.827.295
2021-11-26	2021-11-24	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale		-6.464	182.436	-3,42	13,99	-90.431	2.552.280
2021-11-26	2021-11-24	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale		-31.000	188.900	-14,10	13,44	-416.640	2.538.816
2021-11-24	2021-11-22	4	XAIR	Beyond Air, Inc. Warrants (right to buy)	M - Exercise		-50.000	0	-100,00
2021-11-24	2021-11-22	4	XAIR	Beyond Air, Inc. Common Stock	F - Taxes		-12.536	219.900	-5,39	14,60	-182.988	3.209.880
2021-11-24	2021-11-22	4	XAIR	Beyond Air, Inc. Common Stock	M - Exercise		50.000	232.436	27,41	3,66	183.000	850.716
2021-03-08	2021-03-04	4	XAIR	Beyond Air, Inc. Stock Option (right to buy)	A - Award		25.000	25.000
2021-02-18	2021-02-12	4	XAIR	Beyond Air, Inc. Tranche B Warrant (Right to Buy)	M - Exercise		-23.419	0	-100,00
2021-02-18	2021-02-12	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale		-23.419	182.436	-11,38	6,36	-148.945	1.160.293
2021-02-18	2021-02-12	4	XAIR	Beyond Air, Inc. Common Stock	M - Exercise		23.419	205.855	12,84	4,25	99.531	874.884
2021-02-18	2021-02-11	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale		-1.500	182.436	-0,82	6,28	-9.420	1.145.698
2021-02-08	2021-01-02	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale		-5.700	183.936	-3,01	5,89	-33.573	1.083.383
2020-08-27	2020-08-25	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-1.580	189.636	-0,83	5,95	-9.406	1.128.960
2020-08-25	2020-08-24	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-3.889	191.216	-1,99	5,68	-22.104	1.086.834
2020-08-25	2020-08-21	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-3.246	195.105	-1,64	6,05	-19.651	1.181.127
2020-08-21	2020-08-20	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-3.778	198.351	-1,87	6,29	-23.780	1.248.481
2020-08-21	2020-08-19	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-6.533	202.129	-3,13	6,32	-41.266	1.276.748
2020-08-19	2020-08-18	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-4.578	208.662	-2,15	5,83	-26.691	1.216.562
2020-08-18	2020-08-17	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-4.413	213.240	-2,03	5,72	-25.226	1.218.944
2020-08-17	2020-08-14	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-6.680	217.653	-2,98	5,53	-36.932	1.203.338
2020-08-14	2020-08-13	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-4.088	224.333	-1,79	5,50	-22.494	1.234.392
2020-08-13	2020-08-12	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-4.689	228.421	-2,01	5,30	-24.834	1.209.786
2020-08-12	2020-07-27	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-4.917	278.582	-1,73	6,27	-30.807	1.745.428
2020-08-12	2020-08-11	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-3.910	233.110	-1,65	5,51	-21.553	1.284.949
2020-08-12	2020-08-10	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-3.437	237.020	-1,43	5,42	-18.636	1.285.146
2020-08-10	2020-08-07	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-10.222	245.374	-4,00	5,35	-54.657	1.312.015
2020-08-07	2020-08-06	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-6.192	255.596	-2,37	5,94	-36.777	1.518.112
2020-08-07	2020-08-05	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-3.619	261.788	-1,36	6,16	-22.286	1.612.117
2020-08-06	2020-08-04	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-3.649	265.407	-1,36	6,13	-22.369	1.627.025
2020-08-04	2020-08-03	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-3.814	269.056	-1,40	6,16	-23.489	1.656.981
2020-08-04	2020-07-31	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-2.868	272.870	-1,04	6,27	-17.970	1.709.694
2020-07-31	2020-07-30	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-3.418	275.738	-1,22	6,26	-21.404	1.726.699
2020-07-31	2020-07-29	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-1.827	279.156	-0,65	6,09	-11.135	1.701.400
2020-07-31	2020-07-29	4	XAIR	Beyond Air, Inc. Common Stock	S - Sale	X	-2.516	280.983	-0,89	6,20	-15.596	1.741.757
2020-06-10	2020-06-10	4	STML	STEMLINE THERAPEUTICS INC Stock Option (right to buy)	D - Sale to Issuer		-24.000	0	-100,00
2020-06-10	2020-06-10	4	STML	STEMLINE THERAPEUTICS INC Stock Option (right to buy)	D - Sale to Issuer		-34.000	0	-100,00
2020-06-10	2020-06-10	4	STML	STEMLINE THERAPEUTICS INC Stock Option (right to buy)	D - Sale to Issuer		-18.070	0	-100,00
2020-06-10	2020-06-10	4	STML	STEMLINE THERAPEUTICS INC Stock Option (right to buy)	D - Sale to Issuer		-9.034	0	-100,00
2020-06-10	2020-06-10	4	STML	STEMLINE THERAPEUTICS INC Common Stock	U - Other		-66.346	0	-100,00
2019-06-28	2019-06-25	4	STML	STEMLINE THERAPEUTICS INC Common Stock	A - Award		10.000	65.443	18,04
2019-06-28	2019-06-25	4	STML	STEMLINE THERAPEUTICS INC Common Stock	A - Award		15.000	55.443	37,09
2019-01-10		3	URGN	UroGen Pharma Ltd. Ordinary Shares				76.226
2019-01-10		3	URGN	UroGen Pharma Ltd. Ordinary Shares				76.226
2019-01-10		3	URGN	UroGen Pharma Ltd. Ordinary Shares				76.226
2018-06-22	2018-06-21	4	STML	STEMLINE THERAPEUTICS INC Common Stock	A - Award		13.158	40.443	48,22
2018-05-15	2018-02-16	4	AITB	AIT Therapeutics, Inc. Tranche A Warrant (right to buy)	M - Exercise		-23.419	0	-100,00
2018-05-15	2018-02-16	4	AITB	AIT Therapeutics, Inc. Tranche A Warrant (right to buy)	P - Purchase		23.419	23.419		0,01	234	234
2018-05-15	2018-02-16	4	AITB	AIT Therapeutics, Inc. Tranche B Warrant (right to buy)	P - Purchase		23.419	23.419		0,01	234	234
2018-05-15	2018-02-16	4	AITB	AIT Therapeutics, Inc. Common Stock	M - Exercise		23.419	283.499	9,00	4,25	99.531	1.204.871
2017-06-20	2017-06-19	4	STML	STEMLINE THERAPEUTICS INC Stock Options (right to buy)	A - Award		24.000	24.000
2017-06-20	2017-06-19	4	STML	STEMLINE THERAPEUTICS INC Common Stock	A - Award		10.000	27.285	57,85
2017-06-20		3	AITB	AIT Therapeutics, Inc. Common Stock				520.158
2017-06-20		3	AITB	AIT Therapeutics, Inc. Common Stock				520.158
2016-05-26	2016-05-25	4	STML	STEMLINE THERAPEUTICS INC Stock Options (right to buy)	A - Award		34.000	34.000
2015-06-25	2015-06-23	4	STML	STEMLINE THERAPEUTICS INC Stock Options (right to buy)	A - Award		24.000	24.000
2015-06-25	2015-06-23	4	STML	STEMLINE THERAPEUTICS INC Common Stock	A - Award		10.000	17.285	137,27
2015-04-08	2015-04-06	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-1.592	777.209	-0,20	11,68	-18.595	9.077.801
2015-03-20	2015-03-18	4	STML	STEMLINE THERAPEUTICS INC Stock Options (right to buy)	M - Exercise		-5.421	0	-100,00
2015-03-20	2015-03-18	4	STML	STEMLINE THERAPEUTICS INC Common Stock	S - Sale		-1.388	7.285	-16,00	16,12	-22.375	117.434
2015-03-20	2015-03-18	4	STML	STEMLINE THERAPEUTICS INC Common Stock	M - Exercise		5.421	8.673	166,70	4,09	22.172	35.473
2015-01-06	2015-01-05	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-5.574	778.801	-0,71	13,79	-76.865	10.739.666
2015-01-06	2015-01-04	4	KERX	KERYX BIOPHARMACEUTICALS INC Employee Stock Option (Right to Buy)	A - Award		134.750	134.750
2015-01-06	2015-01-04	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	A - Award		67.375	784.375	9,40
2015-01-02	2014-12-30	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-200.000	717.000	-21,81	14,11	-2.822.000	10.116.870
2014-12-29	2014-12-29	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-87.988	917.000	-8,76	13,98	-1.230.072	12.819.660
2014-12-29	2014-12-26	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-63.500	1.004.988	-5,94	13,98	-887.730	14.049.732
2014-12-29	2014-12-24	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-83.000	1.068.488	-7,21	13,98	-1.160.340	14.937.462
2014-12-29	2014-12-23	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-104.489	1.151.488	-8,32	13,98	-1.460.756	16.097.802
2014-12-23	2014-12-22	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	A - Award		500.000	1.255.977	66,14
2014-10-07	2014-10-06	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-68.800	755.977	-8,34	15,87	-1.091.856	11.997.355
2014-10-07	2014-10-03	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-2.038	824.777	-0,25	16,14	-32.893	13.311.901
2014-09-12	2014-09-12	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-50.000	826.815	-5,70	14,24	-712.000	11.773.846
2014-07-09	2014-07-07	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-1.788	876.815	-0,20	15,75	-28.161	13.809.836
2014-06-23	2014-06-19	4	STML	STEMLINE THERAPEUTICS INC Stock Options (right to buy)	A - Award		20.000	20.000
2014-04-07	2014-04-03	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-1.816	878.603	-0,21	16,46	-29.891	14.461.805
2014-01-06	2014-01-03	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-5.257	880.419	-0,59	12,57	-66.080	11.066.867
2014-01-06	2014-01-02	4	KERX	KERYX BIOPHARMACEUTICALS INC Employee Stock Option (Right to Buy)	A - Award		62.092	62.092
2014-01-06	2014-01-02	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	A - Award		26.611	885.676	3,10
2013-10-08	2013-10-04	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	A - Award		400.000	859.065	87,13
2013-10-07	2013-10-03	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-2.505	459.065	-0,54	10,25	-25.676	4.705.416
2013-07-09	2013-07-05	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-2.440	461.570	-0,53	7,95	-19.398	3.669.482
2013-06-21	2013-06-19	4	STML	STEMLINE THERAPEUTICS INC Stock Options (right to buy)	A - Award		20.000	20.000
2013-04-08	2013-04-05	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-1.795	464.010	-0,39	6,93	-12.439	3.215.589
2013-03-29	2013-03-27	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-31.231	465.805	-6,28	6,88	-214.869	3.204.738
2013-01-28		3	STML	STEMLINE THERAPEUTICS INC Common Stock				3.252
2013-01-04	2013-01-04	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-6.010	497.036	-1,19	2,74	-16.467	1.361.879
2013-01-04	2013-01-02	4	KERX	KERYX BIOPHARMACEUTICALS INC Employee Stock Option (right to buy)	A - Award		75.000	75.000
2013-01-04	2013-01-02	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	A - Award		25.000	503.046	5,23
2012-10-05	2012-10-03	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-746	478.046	-0,16	2,72	-2.029	1.300.285
2012-07-06	2012-07-03	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-684	478.792	-0,14	1,99	-1.361	952.796
2012-04-19	2012-04-18	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	P - Purchase		3.800	479.476	0,80	1,28	4.883	616.127
2012-04-19	2012-04-18	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	P - Purchase		15.300	475.676	3,32	1,30	19.890	618.379
2012-04-04	2012-04-04	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	P - Purchase		71.400	460.376	18,36	1,38	98.525	635.273
2012-01-03	2012-01-03	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	S - Sale		-3.305	388.976	-0,84	2,62	-8.676	1.021.062
2012-01-03	2012-01-02	4	KERX	KERYX BIOPHARMACEUTICALS INC Employee Stock Options (Right to Buy)	A - Award		67.000	67.000
2012-01-03	2012-01-02	4	KERX	KERYX BIOPHARMACEUTICALS INC Common Stock	A - Award		33.000	392.281	9,19